3G5D
Kinase domain of cSrc in complex with Dasatinib
Summary for 3G5D
Entry DOI | 10.2210/pdb3g5d/pdb |
Related | 3F3T 3F3U 3F3V 3F3W |
Descriptor | Proto-oncogene tyrosine-protein kinase Src, N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE, GLYCEROL, ... (4 entities in total) |
Functional Keywords | type ii, dfg-out, tyrosine-protein kinase, dasatinib, atp-binding, kinase, lipoprotein, myristate, nucleotide-binding, phosphoprotein, proto-oncogene, sh2 domain, sh3 domain, transferase |
Biological source | Gallus gallus (chicken) |
Cellular location | Cell membrane (By similarity): P00523 |
Total number of polymer chains | 2 |
Total formula weight | 66645.62 |
Authors | Grutter, C.,Kluter, S.,Rauh, D. (deposition date: 2009-02-05, release date: 2009-06-02, Last modification date: 2023-11-01) |
Primary citation | Getlik, M.,Grutter, C.,Simard, J.R.,Kluter, S.,Rabiller, M.,Rode, H.B.,Robubi, A.,Rauh, D. Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc J.Med.Chem., 52:3915-3926, 2009 Cited by PubMed: 19462975DOI: 10.1021/jm9002928 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.2 Å) |
Structure validation
Download full validation report